Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M142,246Revenue $M16,279Net Margin (%)32.3Altman Z-Score16.3
Enterprise Value $M139,321EPS $2.0Operating Margin %43.6Piotroski F-Score8
P/E(ttm)26.3Beneish M-Score-2.2Pre-tax Margin (%)40.3Higher ROA y-yY
Price/Book19.710-y EBITDA Growth Rate %19.2Quick Ratio1.0Cash flow > EarningsY
Price/Sales8.55-y EBITDA Growth Rate %17.9Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow28.8y-y EBITDA Growth Rate %26.2ROA % (ttm)42.2Higher Current Ratio y-yN
Dividend Yield %1.8PEG1.5ROE % (ttm)86.5Less Shares Outstanding y-yY
Payout Ratio %37.0Shares Outstanding M2,600ROIC % (ttm)143Gross Margin Increase y-yY

Gurus Latest Trades with NVO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NVOKen Fisher 2016-03-31 Reduce-0.03%$46.58 - $58.08
($53.57)
$ 54.712%Reduce -2.35%11,178,809
NVOKen Fisher 2015-12-31 Reduce-0.02%$52.93 - $58.77
($55.36)
$ 54.71-1%Reduce -1.76%11,447,413
NVOMario Gabelli 2015-12-31 Add$52.93 - $58.77
($55.38)
$ 54.71-1%Add 0.65%6,210
NVOKen Fisher 2015-09-30 Reduce-0.07%$52.8 - $60.23
($56.62)
$ 54.71-3%Reduce -5.23%11,652,268
NVORuane Cunniff 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 54.71-3%Reduce -0.59%81,320
NVOMario Gabelli 2015-09-30 Reduce$52.8 - $60.23
($56.62)
$ 54.71-3%Reduce -5.73%6,170
NVOKen Fisher 2015-06-30 Reduce-0.04%$53.39 - $58.02
($56.17)
$ 54.71-3%Reduce -2.88%12,295,864
NVOMario Gabelli 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 54.71-3%Reduce -2.31%6,545
NVORuane Cunniff 2015-06-30 Reduce$53.39 - $58.02
($56.17)
$ 54.71-3%Reduce -0.30%81,800
NVOKen Fisher 2015-03-31 Reduce-0.03%$41.9 - $54.68
($46.05)
$ 54.7119%Reduce -2.91%12,660,235
NVORuane Cunniff 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 54.7119%Reduce -0.17%82,050
NVOMario Gabelli 2015-03-31 Reduce$41.9 - $54.68
($46.05)
$ 54.7119%Reduce -0.30%6,700
NVORuane Cunniff 2014-09-30 Reduce-0.02%$43.9 - $49.03
($46)
$ 54.7119%Reduce -52.87%75,642
NVORuane Cunniff 2014-06-30 Reduce-0.02%$42.28 - $46.52
($44.12)
$ 54.7124%Reduce -33.85%160,492
NVORuane Cunniff 2014-03-31 Reduce-0.01%$36.722 - $48.23
($42.37)
$ 54.7129%Reduce -21.98%242,630
NVORuane Cunniff 2013-12-31 Add0.02%$32.72 - $36.95
($34.88)
$ 54.7157%Add 58.71%310,970
NVOKen Fisher 2013-12-31 Add$32.72 - $36.95
($34.88)
$ 54.7157%Add 0.29%13,553,935
NVOTom Gayner 2013-12-31 Reduce$32.72 - $36.95
($34.88)
$ 54.7157%Reduce -0.23%1,106,000
NVOTom Gayner 2013-09-30 Reduce-0.02%$31.67 - $35.24
($33.61)
$ 54.7163%Reduce -1.51%1,108,500
NVOMario Gabelli 2013-09-30 Reduce$31.67 - $35.24
($33.61)
$ 54.7163%Reduce -0.58%8,520
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NVO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NVO: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about NVO:

    News about NVO:

    Articles On GuruFocus.com
    Jim Simons' Top Holdings Include VeriSign, Chipotle Dec 15 2015 
    Value Investing in BioPharma Nov 18 2015 
    Jim Simons' Five Most-Heavily Weighted Holdings Oct 21 2015 
    Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch Oct 20 2015 
    Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S Sep 14 2015 
    Nintai Returns: Q2 2015 Jul 01 2015 
    Leith Wheeler Investment Funds First Quarter 2015 Review Jun 15 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 
    Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE May 03 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 

    More From Other Websites
    Trading in Novo Nordisk shares by board members, executives and associated persons on 2 May 2016 May 03 2016
    Vanguard Launches 2 Dividend-Oriented International ETFs (VIGI, VYMI) May 02 2016
    How Has Novo’s Share Price Performed since Its Last Earnings? May 02 2016
    Novo Impressed Wall Street with Its 1Q16 Earnings May 02 2016
    Novo Nordisk (NVO) Beats on Q1 Earnings, Retains Outlook May 02 2016
    Trading in Novo Nordisk shares by board members, executives and associated persons on 29 April 2016 May 02 2016
    Novo Nordisk increased adjusted operating profit by 10% in local currencies in the first quarter of... Apr 29 2016
    Novo Nordisk A/S - Share repurchase programme Apr 28 2016
    Novo Nordisk A/S - aktietilbagekøbsprogram Apr 28 2016
    Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 28... Apr 28 2016
    Semaglutide significantly reduces the risk of major adverse cardiovascular events in the SUSTAIN 6... Apr 28 2016
    Stocks Are Mixed as Oil Jumps 3% Apr 26 2016
    5 Large-Cap Stocks to Buy as the S&P Makes New Highs Apr 21 2016
    Novo Nordisk plans to invest more than 100 million euros in production plants in Chartres, France Apr 21 2016
    Novo Nordisk A/S - Reduction of the share capital Apr 18 2016
    Novo Nordisk A/S - Share repurchase programme Apr 18 2016
    How Much Potential Does Saxenda Hold for Novo? Apr 17 2016
    Long views, deep pockets: Danish foundations keep pharma groups healthy Apr 17 2016
    Long views, deep pockets: Danish foundations keep pharma groups healthy Apr 16 2016
    Victoza to Fuel Growth for Novo Nordisk Apr 15 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)